Faculty Summaries
Amy B Lazev, PhD
Amy B Lazev, PhD
Assistant Research Professor
Office Phone: 215-214-3734
Fax: 215-728-2707
Office: 510 TLR, 3rd floor
  • Tobacco Control

    Dr. Lazev is an Assistant Research Professor in the Cancer Prevention and Control Program. Her research program focuses on tobacco control with an emphasis on special populations, including pregnant/postpartum women, low-income and minority populations, college students, persons living with HIV/AIDS and cancer patients. Her research has been funded by the American Lung Association, the American Cancer Society, Pfizer and the American Society of Preventive Oncology/Cancer Research and Prevention Foundation. Dr. Lazev also co-directs the All Smoking Aside Program (ASAP) which provides smoking cessation services to employees and their families.

  • 1. Pfizer Global Research Awards for Nicotine Dependence (GRAND)

    A New Treatment for Smokers with High Negative Affect

    Smokers are interested in, and motivated to, quit smoking. However, only 4-5% of those who make a quit attempt are successful at maintaining cessation. An important subgroup of smokers, those with high negative affect (e.g., depression), have an especially difficult time quitting smoking and maintaining abstinence. Negative affect and nicotine withdrawal (i.e., depression, sleep disturbance, difficulty concentrating, increased appetite, and weight gain) have been identified as key factors driving relapse to smoking. Light therapy, which targets hormones (melatonin) and chronobiology (circadian rhythms), has been empirically validated for treatment of depression including depressed mood, sleep disturbances, increased appetite, and cognitive difficulties. Dr. Lazev is currently investigating the ability of light therapy to reduce negative affect and the symptoms of nicotine withdrawal in order to increase success in smoking cessation.

  • 2. American Society of Preventive Oncology Cancer Prevention Research Fellowship

    College Student Situational Smoking: Trajectories & Cessation Barriers

    Smoking is the single greatest cause of preventable mortality and morbidity in this country. The smoking rate among college students, who make up over a third of the 18-24 year old population, has been increasing at an alarming rate. This increase is in stark contrast to the smoking rate seen in adults with a college degree and suggests that if current college students do not quit smoking, the smoking rate among adults will increase in the future. Dr. Lazev’s prior research shows that among college students who smoke, one-half do not fit the typical smoking “phenotype” (e.g., categorization of smoker in terms of smoking-related behaviors and associated psychosocial variables). In the current study, Dr. Lazev is examining smoking behaviors and patterns to more systemically and comprehensively characterize smoking behavior among college students.